Latanoprost Demo

Latanoprost, the active ingredient in Latanoprost Demo, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. By enhancing fluid outflow from the eye, it helps preserve visual function and delay disease progression.

GNH USA supplies Latanoprost Demo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Latanoprost is a prostaglandin analog used to manage conditions characterized by elevated intra‑ocular pressure.

- Open-angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage and preserve visual field. - Ocular hypertension: lowers eye pressure to prevent progression to glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): improves aqueous outflow to control pressure and reduce risk of optic nerve injury.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual brownish pigmentation. - Eye irritation: transient stinging or burning sensation.

Serious or Rare Side Effects: - Inflammatory eye conditions: uveitis or iritis. - Corneal edema: swelling of the cornea. - Allergic reaction: severe eye swelling or rash.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor intra‑ocular pressure: check pressure regularly after initiation. - Assess for ocular infections: avoid use if active eye infection is present. - Evaluate for hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in patients with corneal disease: may exacerbate existing conditions. - Avoid concurrent use with other prostaglandin analogs: increased risk of side effects. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents, requiring attention to potential effects.

Major Interactions (Avoid): - Concomitant use with other intra‑ocular pressure‑lowering eye drops (e.g., beta‑blockers) may cause excessive pressure reduction. - Use with non‑steroidal anti‑inflammatory eye drops may increase risk of ocular inflammation.

Moderate Interactions (Monitor Closely): - Systemic prostaglandin analogs (e.g., misoprostol) could potentiate systemic effects. - Anticholinergic agents may affect tear production, influencing drug tolerance. - CYP450 inducers are not known to affect latanoprost, but monitor for unexpected efficacy changes.